KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to 0.15.

  • Abbott Laboratories' Debt Ratio fell 2368.9% to 0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15, marking a year-over-year decrease of 2368.9%. This contributed to the annual value of 0.17 for FY2024, which is 1346.6% down from last year.
  • Per Abbott Laboratories' latest filing, its Debt Ratio stood at 0.15 for Q3 2025, which was down 2368.9% from 0.16 recorded in Q2 2025.
  • Over the past 5 years, Abbott Laboratories' Debt Ratio peaked at 0.85 during Q4 2021, and registered a low of 0.15 during Q3 2025.
  • In the last 5 years, Abbott Laboratories' Debt Ratio had a median value of 0.23 in 2022 and averaged 0.27.
  • Within the past 5 years, the most significant YoY rise in Abbott Laboratories' Debt Ratio was 167.51% (2023), while the steepest drop was 7329.97% (2023).
  • Quarter analysis of 5 years shows Abbott Laboratories' Debt Ratio stood at 0.85 in 2021, then fell by 11.91% to 0.75 in 2022, then crashed by 73.3% to 0.2 in 2023, then decreased by 13.47% to 0.17 in 2024, then decreased by 11.39% to 0.15 in 2025.
  • Its Debt Ratio stands at 0.15 for Q3 2025, versus 0.16 for Q2 2025 and 0.16 for Q1 2025.